Companies / ESSA Pharma Inc.
ESSA Pharma Inc.
EPIXCIK 1633932
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Oct 26, 2022 | Biotech Growth N V 10% owner | Buy Open-market buy | Common Shares | $5.97M | +1.5M +25.51% | 7,379,583 | high |
| Nov 1, 2024 | Biotech Growth N V 10% owner | Sell Open-market sale | Common Shares | $3.06M | -2.0M -25.38% | 5,879,583 | medium |
| Nov 1, 2024 | Biotech Growth N V 10% owner | Sell Open-market sale | Common Shares | $3.06M | -2.0M -51.55% | 1,879,583 | medium |
| Nov 1, 2024 | Biotech Growth N V 10% owner | Sell Open-market sale | Common Shares | $3.05M | -2.0M -34.02% | 3,879,583 | medium |
| Nov 1, 2024 | Biotech Growth N V 10% owner | Sell Open-market sale | Common Shares | $2.84M | -1.9M -100.00% | 0 | medium |
| Oct 27, 2022 | Biotech Growth N V 10% owner | Buy Open-market buy | Common Shares | $2.25M | +500K +6.78% | 7,879,583 | high |
| Aug 18, 2021 | Biotech Growth N V 10% owner | Buy Open-market buy | Common Shares | $2.22M | +250K +5.25% | 5,015,814 | high |
| Feb 22, 2021 | Berger Franklin M Director | Buy Open-market buy | Common Shares | $1.54M | +57K +6.33% | 957,244 | high |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EPIX | common | 29668H708 |